Israel Englander Atara Biotherapeutics, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 361,245 shares of ATRA stock, worth $3.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

361,245

Previous 2,920,980 87.63%

Holding current value

$3.07 Million

Previous $1.49 Million 83.28%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.44 - $1.22 $1.13 Million - $3.12 Million	-2,559,735 Reduced 87.63%	361,245 $249,000
Q4 2023 Feb 14, 2024	BUY	$0.23 - $1.74 $311,975 - $2.36 Million	1,356,416 Added 86.7%	2,920,980 $1.49 Million
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $1.58 Million - $3.21 Million	1,055,769 Added 207.5%	1,564,564 $2.52 Million
Q1 2023 May 15, 2023	BUY	$2.8 - $5.46 $1.04 Million - $2.02 Million	369,715 Added 265.83%	508,795 $1.48 Million
Q4 2022 Feb 14, 2023	BUY	$2.85 - $5.18 $11,015 - $20,020	3,865 Added 2.86%	139,080 $456,000

Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $205,807 - $630,419	72,213 Added 114.62%	135,215 $511,000
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $1.79 Million - $3.76 Million	-382,079 Reduced 85.84%	63,002 $491,000
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $3.4 Million - $6.81 Million	403,398 Added 967.78%	445,081 $4.14 Million
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $919,440 - $1.24 Million	-62,547 Reduced 60.01%	41,683 $657,000
Q3 2021 Nov 15, 2021	SELL	$11.99 - $17.9 $3.13 Million - $4.67 Million	-261,067 Reduced 71.47%	104,230 $1.87 Million
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $929,072 - $1.2 Million	-72,077 Reduced 16.48%	365,297 $5.68 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $3.9 Million - $5.77 Million	278,495 Added 175.29%	437,374 $6.28 Million
Q4 2020 Feb 16, 2021	SELL	$12.67 - $26.23 $1.83 Million - $3.79 Million	-144,537 Reduced 47.64%	158,879 $3.12 Million
Q3 2020 Nov 16, 2020	BUY	$11.92 - $15.87 $3.62 Million - $4.82 Million	303,416 New	303,416 $3.93 Million
Q2 2020 Aug 14, 2020	SELL	$7.53 - $14.93 $494,231 - $979,930	-65,635 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$5.69 - $17.78 $669,923 - $2.09 Million	-117,737 Reduced 64.21%	65,635 $559,000
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $2 Million - $3.08 Million	183,372 New	183,372 $3.02 Million
Q3 2019 Nov 14, 2019	SELL	$12.03 - $19.94 $2.34 Million - $3.88 Million	-194,380 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $645,452 - $1.39 Million	33,882 Added 21.11%	194,380 $3.91 Million
Q1 2019 May 14, 2019	BUY	$28.4 - $41.74 $4.2 Million - $6.18 Million	147,971 Added 1181.22%	160,498 $6.38 Million
Q4 2018 Feb 14, 2019	BUY	$30.9 - $42.97 $387,084 - $538,285	12,527 New	12,527 $435,000
Q4 2017 Feb 14, 2018	SELL	$13.2 - $18.1 $286,624 - $393,023	-21,714 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $287,710 - $370,223	21,714	21,714 $359,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $802M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account